ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2023
  • Adani Saga
  • Markets
    • Stocks
    • Global Markets
    • IPO
    • Companies
    • Currency
    • Commodities
  • My Money
  • Calculators
    • Income Tax Calculator
    • Home Loan/EMI Calculator
    • Mutual Fund Returns Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • SIP calculator
    • Lumpsum Calculator
    • SWP Calculator
  • Videos
    • M Se Market
    • Jeb Zindagi Zaroorat
    • Light Camera Stocks
    • Tech Takes
    • Big Bulls Ka Nishana
    • Paisa Wasool
    • Commodity Ke MrityunjayMantra
    • The Right Property Show
  • Economy & Infra
    • Policy & Initiatives
    • Agriculture
    • Telecom
    • Aviation
    • Railways
    • Retail
    • Roadways
    • World Economy
  • Exclusive
    • Wealth Guide
    • Interviews
  • Auto
    • Cars
    • Bikes
    • Electric Vehicle
    • Commercial Vehicles
  • Tech
    • Mobiles
    • Gadgets
    • Reviews
    • Tips and Tricks
    • Apps
  • Real Estate
    • Home Buyers
    • Builders
  • Axis MF
  • Trending
    • Entertainment
    • Politics
    • Lifestyle
    • Travel
    • Sports
    • Viral
    • Education
    • Jobs
Read in App
Business News » India News

US DoJ's probe to have limited impact on Indian pharma cos: Fitch

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
US DoJ's probe to have limited impact on Indian pharma cos: Fitch
"The ongoing probe by the US Department of Justice (DoJ) into suspected price collusion in the pharmaceutical industry is unlikely to have a significant impact on Indian pharma firms," Fitch Ratings said. Representational Image. Image Source: Pixabay

The  ongoing investigation by the US DoJ is likely to have limited impact on Indian pharma companies, said Fitch Ratings on Thursday. 

"The ongoing probe by the US Department of Justice (DoJ) into suspected price collusion in the pharmaceutical industry is unlikely to have a significant impact on Indian pharma firms," Fitch Ratings said in a press release.

The ongoing probe has focused on a few high-priced complex generic drugs so far, which attracted prosecutors' attention due to considerable price increases amid the ongoing policy focus on limiting healthcare costs in the United States (US).

Indian pharma exports to the US are focused mainly on simple generics, competing with a substantial set of competitors offering similar post-patent products, it said.

ALSO READ: Pharma stocks fall sharply as US drug pricing investigation nears completion

Fitch noted that the high level of direct competition along with channel consolidation has caused downward pressure on prices, leading to deflationary trends in many generic drugs.

As per media reports, the anti-trust investigations which began about two years is likely to expand its investigation into more generic drugs and the first charges are likely to be filed possibly by end of this year.

The ratings agency has said that it believes the situation is still evolving amid the current political environment in the US. 

"In any case, we expect the impact to be minimal for Indian pharma, given the already-high price-based competition across most categories over the past few years and the reasonably diversified generic portfolios of Indian pharma companies," cited Fitch in a statement. 

"Overall, we expect the regulatory environment in the US to remain supportive for generics-focused pharma," it further added. 

ALSO READ: Sensex falls on fears drug makers may be charged in US probe

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
US DOJ ProbeEconomyIndian Pharma CompaniesUS Department of JusticeProbeDoJUSgeneric drugs
Written By: Tejal Yerunkar
Updated: Fri, Nov 11, 2016
12:48 pm
Mumbai , ZeeBiz WebDesk
RELATED NEWS
Sensex falls on fears drug makers may be charged in US probe Sensex falls on fears drug makers may be charged in US probe
Pharma stocks fall sharply as US drug pricing investigation nears completion Pharma stocks fall sharply as US drug pricing investigation nears completion
U.S. business rescues pharma cos in quarter one U.S. business rescues pharma cos in quarter one
Indian Rupee, Pharma gain as Trump become's America's 45th president Indian Rupee, Pharma gain as Trump become's America's 45th president
US Department of Justice issues grand jury subpoena to Sun Pharma US Department of Justice issues grand jury subpoena to Sun Pharma

LATEST NEWS

Q3 Results 2023: Jubilant Foodworks, Ashok Leyland, Tata Chemicals, Mahindra Logistics announce quarterly earnings - HIGHLIGHTS

Budget 2023: How experts view govt’s decision to remove tax-free status on insurance policies above Rs 5 lk

Budget 2023: Maturity proceeds of life insurance policies with annual premium of over Rs 5 lakh to be taxed: FM

WhatsApp bans over 36 lakh malicious accounts in India in Dec

Budget 2023: Startups incorporated till March 2024 to get income tax benefits

SC directs WhatsApp to give wide publicity to its 2021 undertaking to Centre on privacy policy

Budget 2023: Massive hike in Senior Citizen Savings Scheme, Post Office Monthly Income Scheme; Govt doubles deposit limit | Details

Should you buy, hold or sell Coal India shares after Q3 results, dividend announcement?

Union Budget: Download Budget 2023-24 PDF Document - Step-by-step guide

Union Budget instrument to push country into huge debt: Sisodia

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
© 2023. India Dot Com Private Limited. All Rights Reserved.
LIVE TV